Latest News

At the University Medical Center Schleswig-Holstein, Campus Kiel, Prof. Dr. Derk Frank has been the new director of the Clinic for Internal Medicine III, focusing on cardiology, angiology and internal intensive care medicine since October 1. Previously, he was the acting director...

Dilated cardiomyopathy, a heart muscle disease, is the most common cause of heart transplants. Dr. Julian Grünewald from the Technical University of Munich (TUM) wants to treat a particularly aggressive form of this disease by intervening in the genome. To do this, he uses a...

The NOAH – AFNET 6 trial which is conducted to evaluate the potential benefit of oral anticoagulation in patients with atrial high rate episodes (AHRE) is going to be terminated prematurely. The reason for early termination is an observed trend towards futility for efficacy...

Almost a year after a SARS-CoV-2 infection, more than half of the participants in a Frankfurt study reported heart problems, such as tachycardia, chest pain and exercise intolerance: that is, symptoms worsening after even minor exertion. A team led by Dr Valentina Puntmann and...

A pill containing aspirin and medications to lower lipids and blood pressure more effectively prevents further adverse cardiovascular events after a heart attack compared with taking the drugs separately. That's the finding of the Europe-wide SECURE study, which has now been...

Atrial fibrillation is recognised and treated more than twice as often in older people using conventional smartphones compared to routine examinations. This is shown by a study presented at this year's European Society of Cardiology (ESC) Congress in Barcelona and published in...

Patients with heart failure frequently also suffer from atrial fibrillation. Their heart then beats irregularly and often too fast, further worsening the heart failure , which may lead to hospitalization. A study funded by the German Center for Cardiovascular Research (DZHK) is...

Patients with atrial fibrillation benefit from early rhythm-maintenance therapy. It prevents complications better than the usual treatment. This is the result of the EAST-AFNET 4 study conducted by the Atrial Fibrillation NETwork (AFNET). Analyses of various subgroups of the...

In a study conducted by the German Center for Cardiovascular Research (DZHK), scientists are investigating a heart valve replacement made of the patient's own tissue, which is unique worldwide according to the current state of knowledge. The goal is to obtain safe implants that...

For the first time, the six German Centers for Health Research (DZG) are launching a joint research program - the DZG Innovation Fund (DZGIF).